[1]刘 岩.胸腺五肽治疗复治菌阳肺结核的临床效果及对患者呼吸功能的影响[J].医学信息,2019,32(08):159-160.[doi:10.3969/j.issn.1006-1959.2019.08.049]
　LIU Yan.Clinical Effect of Thymopentin in the Treatment of Recurrent Pulmonary Tuberculosis and its Effect on Respiratory Function[J].Journal of Medical Information,2019,32(08):159-160.[doi:10.3969/j.issn.1006-1959.2019.08.049]
点击复制

胸腺五肽治疗复治菌阳肺结核的临床效果及对患者呼吸功能的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年08期
页码:
159-160
栏目:
药物与临床
出版日期:
2019-04-15

文章信息/Info

Title:
Clinical Effect of Thymopentin in the Treatment of Recurrent Pulmonary Tuberculosis and its Effect on Respiratory Function
文章编号:
1006-1959（2019）08-0159-02
作者:
刘 岩
（佳木斯市肿瘤结核医院结核内科，黑龙江 佳木斯 154007）
Author(s):
LIU Yan
(Department of Tuberculosis,Cancer Tuberculosis Hospital,Jiamusi 154007,Heilongjiang,China)
关键词:
复治菌阳肺结核; 胸腺五肽; 呼吸功能
Keywords:
Re-treatment of pulmonary tuberculosis; Thymopentin; Respiratory function
分类号:
R521
DOI:
10.3969/j.issn.1006-1959.2019.08.049
文献标志码:
A
摘要:
目的 探讨胸腺五肽治疗复治菌阳肺结核的临床效果及对患者呼吸功能的影响。方法 选取2016年4月~2017年5月我院收治的74例复治菌阳肺结核患者，随机分为对照组和观察组，每组37例。对照组给予常规抗结核药物治疗，观察组加用胸腺五肽注射液治疗，比较两组治疗第1、3、6个月的痰菌阴转率、病灶吸收率、空洞闭合率，以及治疗前后用力肺活量（FVC）、第1秒用力呼气量（FEV1）、FEV1/FVC。结果 治疗后第1、3、6个月，观察组痰菌阴转率、病灶吸收率及空洞闭合率均高于对照组，差异具有统计学意义（P＜0.05）。治疗后，观察组FVC、FEV1、FEV1/FVC水平均高于对照组，差异具有统计学意义（P＜0.05）。结论 胸腺五肽联合常规抗结核药物治疗复治菌阳肺结核患者，可提升复治菌阳肺结核治疗效果，改善患者呼吸功能。
Abstract:
Objective To investigate the clinical effect of thymopentin in the treatment of recurrent pulmonary tuberculosis and its effect on respiratory function. Methods 74 patients with retreatment of pulmonary tuberculosis admitted to our hospital from April 2016 to May 2017 were randomly divided into control group and observation group, with 37 cases in each group. The control group received conventional anti-tuberculosis drugs, and the observation group was treated with thymopentin injection. The sputum negative conversion rate, lesion absorption rate, cavity closure rate, and before and after treatment were compared between the two groups for the first, third, and sixth months of treatment. Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC. Results At the first, third and sixth months after treatment, the negative conversion rate, lesion absorption rate and cavity closure rate of the observation group were higher than the control group, and the difference was statistically significant (P<0.05). After treatment, the levels of FVC, FEV1, and FEV1/FVC in the observation group were higher than those in the control group,the difference was statistically significant (P<0.05). Conclusion Thymopentin combined with conventional anti-tuberculosis drugs for the treatment of re-treatment of pulmonary tuberculosis patients can improve the treatment effect of re-treatment of pulmonary tuberculosis and improve the respiratory function of patients.

参考文献/References:

[1]黄晶.初复治肺结核菌阳患者的耐药性分析与临床研究[J].中国医药指南,2016,14(17):90-91. [2]杜建,刘宇红,李亮.复治肺结核患者采用不同化疗方案的效果评价[J].中国防痨杂志,2016,38(10):850-857. [3]邵蕊,陈广龙.肺结核治疗中胸腺五肽的应用效果研究[J].中国医药指南,2016,14(10):154. [4]张培元.肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70-74. [5]王玉红,董雅坤,王智慧.首次复治涂阳肺结核患者耐药情况分析[J].中国防痨杂志,2017,10(2):23-24. [6]梁冰,梁启德,张凤玲.利福平与左氧氟沙星在复治涂阳肺结核治疗中的相互作用[J].实用医学杂志,2017,33(6):967-970.

相似文献/References:

[1]羊海峰.胸腺五肽联合抗结核方案对老年肺结核患者症状改善及免疫功能的影响[J].医学信息,2022,35(07):168.[doi:10.3969/j.issn.1006-1959.2022.07.044]
　YANG Hai-feng.Effect of Thymopentin Combined with Antituberculosis Regimen on Symptom Improvement and Immune Function in Elderly Patients with Pulmonary Tuberculosis[J].Journal of Medical Information,2022,35(08):168.[doi:10.3969/j.issn.1006-1959.2022.07.044]

更新日期/Last Update: 2019-04-15